A labelling system improves parental comfort and willingness to use topical corticosteroids for paediatric atopic

F Wilson1, E Harnik2, C Gore2,3

  • 1Department of Medicine Faculty of Medicine Imperial College London London UK.

Insights

Parents of children with atopic dermatitis (AD) showed poor knowledge of topical corticosteroids (TCS). A traffic light labeling system significantly improved their willingness to use TCS, suggesting a potential to enhance treatment adherence.

Area of Science:

  • Dermatology
  • Paediatrics
  • Public Health

Background:

  • Atopic dermatitis (AD) is common in children, with topical corticosteroids (TCS) as a primary treatment.
  • Inconsistent packaging of TCS with varying potencies causes confusion, potentially impacting treatment adherence.
  • Parental knowledge and concerns regarding TCS use require evaluation to improve AD management.

Purpose of the Study:

  • To assess parental knowledge and concerns about topical corticosteroids (TCS) for childhood atopic dermatitis (AD).
  • To explore the benefits and preferences for a novel TCS-labelling system.
  • To identify factors influencing adherence to AD treatment regimens.

Main Methods:

  • A mixed-methods approach involving surveys with parents of children with AD.
  • Survey 1 included a knowledge quiz and evaluation of TCS-labelling options.
  • Qualitative and quantitative data were analyzed statistically and thematically.

Main Results:

  • Parents preferred a traffic light system for TCS potency (green, yellow, red).
  • A labelling system significantly increased parental willingness and comfort in using TCS (p ≤ 0.001).
  • Significant knowledge gaps were identified regarding TCS potency, with many over- or underestimating strength.

Conclusions:

  • Parental concerns and poor knowledge regarding TCS use in childhood AD are prevalent.
  • A simple TCS labelling system shows promise for improving treatment adherence.
  • Further research is needed to develop and evaluate refined labelling prototypes for optimal use and adherence.
Abstract

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
401
Labeling Emotion01:20

Labeling Emotion

Emotional labeling is a cognitive process that involves identifying and naming one's emotions, such as anger, fear, happiness, or sadness. It allows individuals to recognize and express their internal emotional states, a critical aspect of emotional regulation and communication. Labeling emotions requires more than mere recognition; it also involves drawing upon memory and contextual cues to understand the current situation and apply a corresponding emotional label. For instance, feeling...
254
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.0K